- Home
- AMN vs ABUS Comparison
AMN vs ABUS Comparison
Compare AMN & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMN
- ABUS
- Stock Information
- Founded
- AMN 1985
- ABUS 2005
- Country
- AMN United States
- ABUS United States
- Employees
- AMN N/A
- ABUS N/A
- Industry
- AMN Assisted Living Services
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- AMN Health Care
- ABUS Health Care
- Exchange
- AMN Nasdaq
- ABUS Nasdaq
- Market Cap
- AMN 806.3M
- ABUS 906.7M
- IPO Year
- AMN 2001
- ABUS N/A
- Fundamental
- Price
- AMN $15.89
- ABUS $4.54
- Analyst Decision
- AMN Buy
- ABUS Strong Buy
- Analyst Count
- AMN 5
- ABUS 2
- Target Price
- AMN $21.70
- ABUS $5.00
- AVG Volume (30 Days)
- AMN 1.1M
- ABUS 950.2K
- Earning Date
- AMN 11-06-2025
- ABUS 11-13-2025
- Dividend Yield
- AMN N/A
- ABUS N/A
- EPS Growth
- AMN N/A
- ABUS N/A
- EPS
- AMN N/A
- ABUS N/A
- Revenue
- AMN $2,716,913,000.00
- ABUS $14,606,000.00
- Revenue This Year
- AMN N/A
- ABUS $138.02
- Revenue Next Year
- AMN N/A
- ABUS N/A
- P/E Ratio
- AMN N/A
- ABUS N/A
- Revenue Growth
- AMN N/A
- ABUS 116.64
- 52 Week Low
- AMN $14.87
- ABUS $2.71
- 52 Week High
- AMN $30.49
- ABUS $5.10
- Technical
- Relative Strength Index (RSI)
- AMN 30.94
- ABUS 50.95
- Support Level
- AMN $15.30
- ABUS $4.41
- Resistance Level
- AMN $20.90
- ABUS $4.87
- Average True Range (ATR)
- AMN 1.14
- ABUS 0.24
- MACD
- AMN -0.44
- ABUS -0.01
- Stochastic Oscillator
- AMN 10.22
- ABUS 39.39
About AMN AMN Healthcare Services Inc
AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are; nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions. A majority of its revenue is generated from the nurse and allied solutions segment which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.